Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12612001179820
ACTRN12612001179820
Not yet recruiting
未知

An observational study examining gene expression in term placentas collected from women whose pregnancies were complicated by preeclampsia or intrauterine growth restriction compared to those from healthy pregnancies.

The University of Adelaide0 sites600 target enrollmentNovember 6, 2012
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsGene expression in placentas collected from fetuses from pregnancies complicated by preeclampsia or intrauterine growth restriction compared to those from healthy pregnancies.Reproductive Health and Childbirth - Fetal medicine and complications of pregnancy

Overview

Phase
未知
Intervention
Not specified
Conditions
Gene expression in placentas collected from fetuses from pregnancies complicated by preeclampsia or intrauterine growth restriction compared to those from healthy pregnancies.
Sponsor
The University of Adelaide
Enrollment
600
Status
Not yet recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 6, 2012
End Date
TBD
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Caucasian women pregnant with singleton, non\-smokers, BMI 20\-35\. Both pregnant mothers and fathers of the pregnancy (where possible) will be asked to supply a saliva sample for genome\-wide SNP genotyping.

Exclusion Criteria

  • •non caucasian ethnicity, smokers, BMI over 35 or under 20, non english speaking

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
An Investigative Study to characterize gene expression patterns in myeloid cells that are triggered during acute asthma exacerbations, and to identify associated genes/gene networks that are Omalizumab sensitive.
EUCTR2012-002106-48-IEniversity College Dublin20
Not yet recruiting
Not Applicable
Patients with SARSCOV-2 with its mRNA levels of Blimp1 alpha and beta
CTRI/2020/12/029868SN Medical college
Not yet recruiting
Phase 2
Treatment of Rheumatoid Arthritis with Unani Medicine and its relation with genesHealth Condition 1: D898- Other specified disorders involving the immune mechanism, not elsewhere classified
CTRI/2023/05/053034Central Council for Research in Unani Medicine
Recruiting
Not Applicable
Analysis o expression level of genes and proteins in the corneaAnalysis o expression level of genes and proteins in the cornea
JPRN-UMIN000043249Doshisha University18
Completed
Phase 4
Investigating the Immune Response to 4CMenB in InfantsMeningitis
NCT02080559University of Oxford187